Marpai, Inc.
Marpai, Inc.
Your view on MRAI
Overview
What the company does, where it operates, and who runs it.
About Marpai, Inc.
- Industry
- Medical - Healthcare Plans
- Sector
- Healthcare
- CEO
- Damien Francis Lamendola
- Headquarters
- 401 Park Avenue South, New York City, NY, US
- Industry
- Medical - Healthcare Plans
- Sector
- Healthcare
- CEO
- Damien Francis Lamendola
- Headquarters
- 401 Park Avenue South, New York City, NY, US
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services.
It also develops artificial intelligence and healthcare technology that enables the analysis of data to predict and prevent events related to diagnostic errors, hospital visits, and administrative issues. The company was incorporated in 2021 and is headquartered in New York, New York.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Marpai, Inc., and the rating behind it. MRAI last traded at $0.60; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Marpai, Inc.. Starting points for Marpai, Inc.: EPS -$0.65, beta 4.65 — an Medical - Healthcare Plans name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Marpai, Inc.. Marpai, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Marpai, Inc.. Trailing twelve-month EPS for Marpai, Inc. stands at -$0.65. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Marpai, Inc.. Marpai, Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Marpai, Inc. valued side by side against its closest peers. Marpai, Inc. is measured against Medical - Healthcare Plans peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Marpai, Inc., and how their positions are changing. At a $9.2M market value, institutional positions materially move Marpai, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Marpai, Inc. executives and directors. Shares of Marpai, Inc. have traded between $0.34 and $1.78 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Marpai, Inc.. Marpai, Inc. is a $9.2M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Marpai, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Marpai, Inc.. Coverage tracks Marpai, Inc. within Medical - Healthcare Plans (Healthcare). Press releases and market coverage, newest first.